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The b1-integrin cytoplasmic domain consists of a membrane proximal subdomain com-
mon to the four known isoforms (“common” region) and a distal subdomain specific for
each isoform (“variable” region). To investigate in detail the role of these subdomains in
integrin-dependent cellular functions, we used b1A and b1B isoforms as well as four
mutants lacking the entire cytoplasmic domain (b1TR), the variable region (b1COM), or
the common region (b1DCOM-B and b1DCOM-A). By expressing these constructs in
Chinese hamster ovary and b1 integrin-deficient GD25 cells (Wennerberg et al., J Cell Biol
132, 227–238, 1996), we show that b1B, b1COM, b1DCOM-B, and b1DCOM-A molecules
are unable to support efficient cell adhesion to matrix proteins. On exposure to Mn11
ions, however, b1B, but none of the mutants, can mediate cell adhesion, indicating
specific functional properties of this isoform. Analysis of adhesive functions of trans-
fected cells shows that b1B interferes in a dominant negative manner with b1A and
b3/b5 integrins in cell spreading, focal adhesion formation, focal adhesion kinase ty-
rosine phosphorylation, and fibronectin matrix assembly. None of the b1 mutants tested
shows this property, indicating that the dominant negative effect depends on the specific
combination of common and B subdomains, rather than from the absence of the A
subdomain in the b1B isoform.
INTRODUCTION
Integrins are a/b heterodimeric transmembrane cell
surface receptors that mediate cell adhesion and mi-
gration and also the bidirectional transfer of informa-
tion across the plasma membrane. These properties
are essential in regulating several biological processes,
including morphogenesis, immune response, cell
growth, differentiation, and survival (Hynes, 1992;
Ruoslahti and Reed, 1994).
The cytoplasmic domains of integrin subunits are
required for these functions (Hibbs et al., 1991;
Yamada and Miyamoto, 1995; Dedhar and Hannigan,
1996). In vitro, the isolated b1 cytoplasmic domain
was shown to bind talin, a-actinin, and paxillin, three
cytoskeletal proteins that mediate the anchorage of
actin filaments to the plasma membrane (Chen et al.,
1995; Otey et al., 1993; Schaller et al., 1995). Binding of
the b1 cytoplasmic sequence to focal adhesion kinase
(FAK), a tyrosine kinase specifically localized to focal
adhesions, and to the serine/threonine kinase inte-
grin-linked kinase has also been reported (Schaller et
al., 1995; Hannigan et al., 1996). In vivo, the b1 cyto-
plasmic domain is sufficient for its localization to pre-
formed focal adhesions (LaFlamme et al., 1992,
Akiyama et al., 1994) and for the initiation of signaling
to FAK (Lukashev et al., 1994). A model has been
proposed in which the b1 subunit cytoplasmic domain‡ Corresponding author.
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contains a default signal for interaction with cytoskel-
etal molecules that is masked by the a subunit cyto-
plasmic domain (Briesewitz et al., 1993; Ylanne et al.,
1993). In response to matrix ligands or to multivalent
antibody binding, the inhibitory effect of the a subunit
can be released, and integrins can interact with cy-
toskeletal and signaling molecules (Miyamoto et al.,
1995a,b).
Integrins can activate different intracellular signals,
including tyrosine phosphorylation of a number of
cellular proteins, elevation of the intracellular calcium
level, cytoplasmic alkalinization, alteration in phos-
pholipid metabolism, and activation of MAP kinases
(Clark and Brugge, 1995; Schaller et al., 1995). The
most studied pathway is represented by the activation
of the FAK tyrosine kinase (Guan et al., 1991; Burridge
et al., 1992). Tyrosine-phosphorylated FAK can func-
tion as a docking site for both cytoskeletal proteins,
such as paxillin and talin, and signaling molecules,
such as Src family tyrosine kinases, Grb2, and phos-
phatidyl inositol-3 kinase (Schaller and Parson, 1994;
Burridge and Chrzanowska-Wodnicka, 1996). These
interactions are important for coordinating actin cy-
toskeleton organization and gene expression and,
thus, for regulating cell migration, proliferation, dif-
ferentiation, and survival (Schwartz et al., 1995).
In addition to outside-in signaling, integrins can
also transduce signals from the inside to the outside of
the cell. The inside-out signaling occurs mainly in the
form of regulation of the ligand-binding affinity state
(Ginsberg et al., 1992; O’ Toole et al., 1994). By acting
on the cytoplasmic domain, intracellular signals can
modify the conformation of the integrin extracellular
domain and, therefore, modify ligand binding capac-
ity (O’ Toole et al., 1994).
The amino acid sequences of the b cytoplasmic do-
main that are important for outside-in and inside-out
signaling have been mapped in some detail. Three
major sites in the b1 cytoplasmic domain, termed
cyto-1, 2, and 3, are important for localization of the
integrin heterodimer to focal adhesions (Reszka et al.,
1992). The cyto-1 site is proximal to the lipid bilayer
and partially overlaps with the putative binding sites
for FAK, paxillin, and a-actinin (Otey et al., 1993;
Schaller et al., 1995). In b3-integrin, a region N-termi-
nal to cyto-1 interacts with the highly conserved se-
quence GFFKR of the a subunits and is involved in the
regulation of ligand-binding affinity (Hughes et al.,
1996). The cyto-2 and cyto-3 sites correspond to two
NPXY motifs and are also important for regulating the
affinity state of the ectodomain (O’Toole et al., 1995).
Interestingly, four isoforms of the b1-integrin exist
in humans, differing in their cytoplasmic sequence as
well as in their functional properties (Balzac et al.,
1994; Fornaro et al., 1995; Belkin et al., 1996). Based on
the structural properties of the four splicing variants,
the b1 cytoplasmic domain can be divided in two
subdomains that we refer to as “common” and “vari-
able” subdomains, respectively. The common subdo-
main consists of the 25 amino acid residues proximal
to the membrane coded for by exon 6 (Altruda et al.,
1990; Baudoin et al., 1996) and is shared by all four
variants. This region is highly conserved among dif-
ferent b subunits and contains the cyto-1 site (Reszka
et al., 1992) and the putative binding sites for FAK,
paxillin (Schaller et al., 1995), and a-actinin (Otey et al.,
1993). The variable subdomain extending toward the
C terminus is coded for by different exons (Baudoin et
al., 1996) and characterizes the four different b1 iso-
forms: b1A, b1B, b1C, and b1D. The b1A variable
subdomain contains cyto-2 and cyto-3 sites, whereas
that of b1B is characterized by a unique amino acid
sequence lacking both sites. We have shown that these
structural features have important consequences for
the functional properties of b1A and b1B. In fact,
whereas b1A is capable of triggering FAK tyrosine
phosphorylation and localizing to focal adhesions,
b1B lacks both functions (Balzac et al., 1994). More-
over, b1B acts as a dominant negative inhibitor, when
expressed in Chinese hamster ovary (CHO) cells, by
interfering with cell spreading and migration pro-
moted by endogenous b1A (Balzac et al., 1993, 1994).
To investigate the structural basis of the b1B domi-
nant negative effect further, we prepared different mu-
tants lacking either the b1 cytoplasmic domain vari-
able or common region. These constructs, together
with b1B, were expressed both in GD25 cells, which
express aVb3/5 and lack b1 as a consequence of gene
knockout (Wennerberg et al., 1996), and in CHO cells,
which express endogenous hamster b1A. In these cel-
lular systems we show that b1B acts as dominant
negative on adhesive and signaling function of both
b1- and b3/5-integrins. Analysis of mutants molecules
shows that this dominant negative action is attribut-
able to the unique b1B cytoplasmic domain.
MATERIALS AND METHODS
Antibodies and Reagents
The following antibodies were used: the rat anti-human b1 mAb 13
(Akiyama et al., 1989) was a gift from K. Yamada (National Institutes
of Health, Bethesda, MD); the activating mouse anti-human b1 mAb
TS2/16 (Hemler et al., 1984) was obtained from American Type
Culture Collection (Rockville, MD); the mouse anti-human b1 mAb
12G10 was characterized previously (Mould et al., 1995); the rat
anti-mouse b1 mAb 9EG7, with human cross-reactivity (Lenter et al.,
1993), was a gift from D. Vestweber (ZMBE Technologiehof, Muen-
ster, Germany); the blocking mouse anti-human b1 mAb AIIB2
(Werb et al., 1989) was a gift from C. Damsky (Department of
Stomatology, University of California, San Francisco, CA); the in-
hibitory PB1 mAb against hamster a5b1 heterodimer was obtained
from the Developmental Studies Hybridoma Bank (University of
Iowa, Iowa City, IA); the blocking anti-mouse aV H9.2B8 mAb
(Moulder et al., 1991) was purchased from PharMingen (San Diego,
CA); the rat anti-mouse a6 mAb GoH3 (Sonnenberg et al., 1988) was
a gift from A. Sonnenberg (The Neederland Cancer Institute, Am-
sterdam, the Netherlands); the anti-talin mAb 8d4 was obtained
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from Sigma (St. Louis, MO); the anti a-actinin mAb 1682 was from
Chemicon (Temecula, CA); rabbit polyclonal antisera to human
fibronectin and to aV, a3, and a5 integrin cytoplasmic domains
were produced in our laboratory (Tarone et al., 1984, Defilippi et al.,
1992); the FAK 4 polyclonal antibody and the mAb FAK9.2 for FAK
immunoprecipitation and Western blotting, respectively, were pre-
pared in our laboratory as described previously (Defilippi et al.,
1995); a mouse anti-paxillin mAb and the anti-phosphotyrosine
mAb PY20 were purchased from Transduction Laboratories (Not-
tingham, UK); fluorescein-labeled phalloidin, fluorescein-labeled
goat anti-mouse IgG, rhodamine-labeled goat anti-mouse IgG, and
rhodamine-labeled goat anti-rabbit IgG were all from Sigma. Fi-
bronectin was purified from human plasma by affinity chromatog-
raphy on gelatin-Sepharose according to the method of Engvall and
Ruoslahti (1977); mouse laminin-1 was obtained from GIBCO BRL
(St. Louis, MO); the peptides GRGDSP and GRGESP were synthe-
sized by Drs. L. Lozzi and P. Neri (University of Siena, Siena, Italy).
Integrin b1 Cytoplasmic Domain Mutagenesis and
cDNA Vector Construction
Restriction enzymes, T4 DNA ligase, and a Klenow fragment of
DNA polymerase were from New England Biolabs (Beverly, MA);
Taq DNA polymerase was from Promega (Madison, WI). The SV40-
based expression vector pECE (Ellis et al., 1986) containing the b1A
and b1B cDNA fragments was described previously (Giancotti and
Ruoslahti, 1990; Balzac et al., 1993). These plasmids were used to
generate four cytoplasmic domain deletion mutants of human b1-
integrin as follows. The HindIII cloning site of pECE was eliminated
(pECE/H2), and the 417-bp HindIII cDNA fragment, containing the
entire cytoplasmic domain and a part of the transmembrane domain
of human b1A, was excised and substituted with either a HindIII
synthetic oligonucleotide fragment constituting the transmembrane
and the cytoplasmic domain up to isoleucine residue 762 or a
HindIII PCR fragment extending to the end of the b1 cytoplasmic
common subdomain (threonine residue 782), followed by two stop
codons, to generate the plasmids pECE/H2-b1TR and pECE/H2-
b1COM, respectively. The internal deletion of the common subdo-
main (from isoleucine 762 to threonine 782 in the amino acid se-
quence) of b1A and b1B cDNA fragments was obtained by
recombinant PCR mutagenesis (Higuchi, 1990). The resulting PCR
fragments were used to generate the plasmid pECE/H2-
b1DCOM-A and pECE/H2-b1DCOM-B. Each mutant cDNA se-
quence was confirmed by dideoxy sequencing (T7 sequencing kit;
Pharmacia Biotech, Upsala, Sweden).
Cells and Transfections
CHO cells expressing human b1A- or b1B-integrin isoforms or the
relative deletion mutants b1TR, b1COM, b1DCOM-A, and
b1DCOM-B were obtained by cotransfection with pSV2-neo using
the calcium phosphate precipitation method as described (Balzac et
al., 1993). The GD25 cell line, derived from b1-deficient embryonic
stem cells (Wennerberg et al., 1996), was transfected with b1B, b1A,
b1TR, and b1COM expression constructs, together with the plasmid
pECV6-hyg (Belt et al., 1989), by electroporation. Resistant popula-
tions were selected in medium containing 300 mg/ml hygromycin b
(Boehringer Mannheim, Mannheim, Germany).
After 10 d of selection, both CHO and GD25-positive cells were
sorted for b1 expression by a modification of the panning method
(Margolskee et al., 1993). Briefly, transfected cells were adsorbed to
bacteriological dishes coated with 10 mg/ml sterile-filtered anti-
human b1 mAb TS2/16 in PBS and allowed to attach for 5–30 min
at 4°C. Dishes were then rinsed several times with PBS to remove
unbound cells, and adherent cells were detached from the substrate
by trypsin-EDTA treatment and transferred to tissue culture dishes.
To select populations expressing high levels of all b1 forms used,
five cycles of panning in stringent conditions (short time of cell
adhesion) were performed.
Integrin Analysis by Flow Cytometry and
Immunoprecipitation
The expression level of transfected b1 integrins and their conforma-
tional state was measured by FACS analysis. Cells were suspended
in PBS [10 mM phosphate buffer (pH 7.3) and 150 mM NaCl]
containing 1 mg/ml BSA. One millimolar MnCl2 was also added
when indicated. The cells were then incubated for 1 h at 4°C with
saturating concentrations of b1 monoclonal antibodies followed by
fluorescein-labeled goat anti-mouse IgG. After washing, cells were
analyzed (5000 per sample) in a FACScan (Becton Dickinson, Moun-
tain View, CA) equipped with 5 W argon laser at 488 nm.
Integrins were immunoprecipitated from cells labeled with 125I as
described previously (Rossino et al., 1990; Balzac et al., 1994).
Cell Adhesion and Spreading Assays
Cell adhesion and spreading assays to matrix-coated microtiter
plates were performed as described previously (Balzac et al., 1994).
To analyze the role of divalent cations in adhesion, cells were plated
in “adhesion buffer” [20 mM Tris (pH 7.4), 135 mM NaCl, 5 mM
KCl, 2 mM l-glutamine, 1.8 mM glucose, and 1% BSA] containing 1
mM MnCl2, MgCl2, or CaCl2. Where indicated, adhesion was
blocked by addition of the b1 mAb AIIB2 (1:5 dilution of culture
supernatant) or 0.5 mg/ml GRGDSP peptide; the GRGESP peptide
was also used as control. Cell adhesion was evaluated by colorimet-
ric assay for acid phosphatase activity as described (Defilippi et al.
1991).
Fibronectin Matrix Assembly Assay
Matrix assembly was evaluated by adding exogenous purified hu-
man plasma fibronectin (Engvall and Ruoslahti, 1977) to a final
concentration of 200 nM for 2 d to confluent cell monolayers grown
on glass coverslips in medium containing 1% serum. Where indi-
cated, inhibitory mAb PB1 against hamster a5b1 or mAb H9.2B8
against mouse aV was used (10 mg/ml). The resulting fibronectin
matrix was then visualized by immunofluorescence.
The same protocol was used to quantitate fibronectin assembly
using 100 nM 125I-labeled fibronectin (specific activity, 0.08 mCi/
nM). A deoxycholate-insoluble fraction was obtained from cell
monolayers as described (McKeown-Longo and Mosher, 1985; Wu
et al., 1993, 1995). 125I-labeled fibronectin incorporated into the de-
oxycholate-insoluble extracellular matrix was analyzed by reducing
SDS-PAGE (6% running gel) and autoradiography.
Immunofluorescence Microscopy
For immunofluorescence cells were seeded on circular (1-cm-diam-
eter) glass coverslips in 12-well plates and grown for the indicated
time. Where indicated, coverslips were coated with 10 mg/ml hu-
man plasma fibronectin. Immunofluorescence staining of paraform-
aldehyde-fixed cells was performed using a standard protocol (Bal-
zac et al., 1993). A 1:500 dilution of the polyclonal antibody to
human fibronectin, a 0.5 mg/ml solution of paxillin mAb, a 1:200
dilution of the aV cytoplasmic domain polyclonal antibody, and a
10 mg/ml solution of mAb TS2/16 were used. Bound primary
antibodies were then visualized by appropriate rhodamine-labeled
secondary antibodies. In some experiments cells were double
stained with fluorescein-conjugated phalloidin.
Measurement of Cellular Contractility
Silicone rubber substrata for assessing cellular contractility were
made as described previously (Harris et al., 1980; Danowski, 1989).
Films were produced by glow discharge polymerization (5 sec, 20
mA). Briefly, 0.5 ml of silicone rubber (dimethyl polysiloxane; vis-
cosity, 10,000–60,000 centistokes; Sigma) was aliquoted into tissue
culture dishes and allowed to spread for 24 h. The top of the silicone
was then coated with a thin layer of gold-palladium using a cold
Dominant Negative Effect of b1B-Integrin
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sputter coater. The UV glow discharge that occurred during the
gold-palladium coating polymerized the silicone rubber. Cells were
plated for 1 day on the cross-linked rubber substrata in growth
medium with 10% serum, and the presence or absence of wrinkles
was examined using an inverted phase-contrast Leitz microscope.
Detection of Phosphotyrosine-containing Proteins
To specifically trigger tyrosine phosphorylation of intracellular pro-
teins mediated by the transfected or endogenous integrins, cells
were plated on plastic dishes coated with specific monoclonal anti-
bodies as described (Balzac et al., 1994). Cells were lysed in the
presence of phosphatase inhibitors, and FAK was immunoprecipi-
tated as described (Retta et al., 1996). After SDS-PAGE, proteins
were transferred to nitrocellulose and processed for Western blot-
ting with the anti-phosphotyrosine mAb PY20 followed by peroxi-
dase-conjugated anti-mouse IgG (Sigma). Bound antibodies were
visualized by an ECL detection method (Amersham, Buckingham-
shire, UK). After stripping with 2% SDS at 42°C for 1 h to remove
bound antibodies, the filter was reprobed with the mAb FAK9.2 to
visualize the level of FAK protein.
Coimmunoprecipitation of Proteins Interacting with
the b1 Cytoplasmic Domain
Transfected CHO cells from confluent culture dishes were sus-
pended by EDTA treatment and incubated with 10 mg of purified
TS2/16 mAb to human b1 for 30 min at 4°C on a rotator. Cells were
centrifuged (1000 rpm, 3 min), and the pellets were extracted for 3
min on ice with 50 mM PIPES buffer (pH 6.9) containing 0.5%
digitonin, 1 mM MgCl2, 1 mM EGTA, 10 mg/ml leupeptin, 10
mg/ml pepstatin, and 0.5 mM PMSF. Cell extracts were centrifuged
(12,000 rpm, 30 min, 4°C), and the resulting supernatants were
incubated at 4°C for 45 min with protein G-Sepharose beads. Im-
munoprecipitates were washed in the same buffer, boiled in SDS
sample buffer, and separated by 8% SDS-PAGE. Proteins were
transferred onto Immobilon membranes and processed for Western
blotting with 8d4 mAb against talin, 1682 mAb against a-actinin, or
FAK9.2 mAb against FAK.
RESULTS
Preparation of b1-Integrin Cytoplasmic Domain
Variants and Expression in CHO and b1-Null Cells
The cytoplasmic domain of b1-integrin consists of a
membrane proximal subdomain, shared by all four b1
isoforms (common subdomain), and a distal subdo-
main toward the C terminus, unique for each isoform
(variable subdomain) (Figure 1). To investigate the
specific role of these two b1 cytoplasmic subdomains,
we have generated the following mutants (Figure 1):
b1TR, lacking the entire cytoplasmic domain; b1COM,
containing only the common subdomain; and
b1DCOM-B and b1DCOM-A, in which the common
subdomain has been deleted and the variable B and A
subdomains are directly linked to the transmembrane
segment. These constructs and the natural b1B and
b1A isoforms were expressed in CHO cells (Figure
2A) and in the mouse GD25 fibroblastic cell line,
which lacks endogenous b1 as a consequence of gene
inactivation (Fässler et al., 1995; Wennerberg et al.,
1996) (Figure 2, B and C). Previous results showed that
human b1A and b1B isoforms correctly associated
with endogenous a subunits in CHO cells (Balzac et
al., 1993, 1994). Identical results were obtained with
the four b1 mutants described above (Retta, Balzac,
Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo,
and Tarone, unpublished results). The major integrin
complexes at the GD25 cell surface are a6b4-, aVb3-,
and aVb5-integrins (Figure 2C; Wennerberg et al.,
1996). Transfection of these cells with the above b1
constructs led to surface expression of b1 integrin
heterodimers with the endogenous a3, a5, and a6
subunits but not with the aV subunit (Figure 2C). A
significant amount of a5 was detected at the surface of
untransfected GD25 cells, suggesting that a fraction of
the molecule can still reach the cell surface in the
absence of the b subunit.
Adhesive Properties of b1-Integrin Cytoplasmic
Variants
The functional properties of GD25 and CHO cells
transfected with either the b1B or b1A isoform or the
four b1 cytoplasmic domain mutants were evaluated
by testing their adhesive properties toward fibronectin
and laminin-1. A previous report showed that GD25
b1-null cells adhere to fibronectin via aVb3 integrin
(Wennerberg et al., 1996). Here we show that GD25-
b1B cells have reduced ability to spread on fibronectin
and retain a stellate shape with numerous cytoplasmic
protrusions (Figure 3A, b). Both untransfected GD25
and GD25-b1A cells, on the other hand, showed nor-
mal spreading capacity (Figure 3A, a and c). Differ-
ences in spreading capacity between GD25-b1B and
Figure 1. Schematic representation of b1A, b1B, and cytoplasmic
domain deletion mutants prepared for these studies. The amino acid
sequences of b1A and b1B cytoplasmic domain are indicated. The
b1COM mutant was truncated at threonine 782 and contains only
the subdomain common to the different human b1 isoforms; the
b1TR mutant was truncated at isoleucine residue 762 and lacks the
entire cytoplasmic domain; the b1DCOM-A and b1DCOM-B lack
the common subdomain, so that the distal A and B subdomains,
respectively, are directly linked to the transmembrane segment.
These mutants were prepared by oligonucleotide-mediated and
recombinant PCR mutagenesis as described in MATERIALS AND
METHODS.
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GD25 cells were maximal 1 h after plating on fibronec-
tin in serum-free medium.
This result in GD25 cells extends previous data ob-
tained in CHO cells (Balzac et al., 1994) and indicates
that b1B is capable of a trans-dominant negative effect
toward aVb3 integrin. Interestingly, neither b1TR nor
b1COM caused reduced spreading when expressed
both in GD25 (Figure 3A, d and e) and CHO cells
(Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De
Leo, Silengo, and Tarone, unpublished results). More-
over, also the b1DCOM-A and b1DCOM-B mutants
did not interfere with cell spreading (Retta, Balzac,
Ferraris, Belkin, Fässler, Humphries, De Leo, Silengo,
and Tarone, unpublished results).
We then tested adhesion to laminin-1. GD25 cells do
not adhere to laminin-1, allowing the direct evaluation
of adhesive properties of b1 cytoplasmic domain vari-
ants in the absence of functional endogenous inte-
grins. Although expression of b1A restored the ability
of GD25 cells to adhere and spread on laminin-1,
expression of the b1B isoforms did not (Figure 3B,
a–c), indicating that a/b1B heterodimers do not bind
efficiently to laminin-1. Lack of adhesion to laminin-1
was also observed in b1TR- and b1COM-transfected
GD25 cells (Figure 3C).
To assay whether the adhesive capacity of GD25-
b1B cells can be modified, we tested Mn11 ions,
which are known to increase binding affinity of inte-
grins for their ligands (Gailit and Ruoslahti, 1988).
Plating in the presence of 1 mM Mn11 restored adhe-
sive capacity to laminin-1 of GD25-b1B (Figure 3, B, b
and e, and C) but not of GD25-b1TR and GD25-
b1COM cells (Figure 3C), thus indicating that the b1B
isoform has unique functional properties with respect
to the artificial mutants. Blocking antibodies to human
b1 (mAb AIIB2) prevented Mn11-dependent adhe-
sion in GD25-b1B cells, indicating that Mn11 induces
b1B to bind its ligand (Figure 3C). Mg11 and Ca11
were also tested and found to be ineffective in induc-
ing cell adhesion to laminin-1 (Retta, Balzac, Ferraris,
Belkin, Fässler, Humphries, De Leo, Silengo, and
Tarone, unpublished results). Interestingly, adhesion
of GD25-b1B cells to laminin-1 resulted in poor
spreading with respect to GD25-b1A cells (Figure 3B,
e and f).
Figure 2. Surface expression of
transfected b1 variants in CHO
and GD25 cells. CHO and GD25
cells were transfected with DNA
constructs for human b1B or b1A
or for the b1 cytoplasmic domain
deletion mutants indicated, and
positive cells were sorted by pan-
ning on b1 antibodies as de-
scribed in MATERIALS AND
METHODS. (A and B) To detect
surface expression of transfected
b1 variants, CHO (A) and GD25
(B) transfectants were stained
with mAb TS2/16 to human b1,
followed by fluorescein-labeled
anti-mouse IgG, and analyzed by
FACS. The level of b1 surface ex-
pression reported as fluorescence
intensity is shown. Untransfected
cells were included as a negative
control. (C) Integrin heterodimers
in 125I-surface-labeled GD25,
GD25-b1B, and GD25-b1A cells as
detected by nonreducing SDS-
PAGE and autoradiography of im-
munoprecipitated integrins with
antibodies specific for b1, a3, a5,
a6, and aV subunits.
Dominant Negative Effect of b1B-Integrin
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Figure 3.
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To test whether lack of adhesion of b1B-transfected
cells was restricted to laminin-1, we examined the
attachment of these cells to fibronectin-coated dishes.
Previous results showed that expression of b1A in
GD25 cells leads to altered susceptibility to the Gly-
Arg-Gly-Asp-Ser-Pro (GRGDSP) peptide (Wenner-
berg et al., 1996). In agreement with this, although
adhesion of GD25 cells to fibronectin was completely
inhibited by 500 mg/ml GRGDSP peptide, only 50%
inhibition was observed in GD25-b1A cells (Figure
3D), indicating that transfected b1A modifies adhesive
properties of GD25 cells to fibronectin. On the other
hand 500 mg/ml GRGDSP peptide fully inhibited ad-
hesion of GD25-b1B on fibronectin, as in the case of
GD25 cells (Figure 3D), indicating that the b1B mole-
cule does not significantly contribute to cell adhesion
to fibronectin.
Cytoplasmic Domain Sequences Affect b1-Integrin
Ectodomain Conformation
The data discussed above suggest that integrin het-
erodimers containing the b1B subunit are expressed at
the cell surface in a conformation that does not allow
efficient binding to matrix ligands. To investigate this
possibility further, we used two antibodies, mAb
12G10 and mAb 9EG7, which recognize epitopes ex-
pressed only in the ligand-competent and ligand-oc-
cupied b1 (Lenter et al., 1993; Mould et al., 1995).
Expression of these epitopes reflects changes in inte-
grin ectodomain conformation, which can also be in-
duced by exposing b1 to Mn11 (Bazzoni et al., 1995;
Mould et al., 1995). The binding of both 12G10 and
9EG7 mAbs to the b1 extracellular domain was always
compared with that obtained with mAb 13, which
recognizes a constitutive epitope in human b1. When
cells were probed with mAb 12G10, virtually no bind-
ing was detected on GD25-b1B and GD25-b1COM
cells, unless Mn11 was present in the medium (Figure
4, A and B). On the contrary, a high level of mAb
12G10 binding was detected on GD25-b1A and GD25-
b1TR cells, addition of Mn11 causing a further in-
crease (Figure 4, A and B). By comparing the binding
values of mAb 12G10 with those of mAb 13, we esti-
mated that only 5–8% of the b1B at the cell surface
expressed the 12G10 mAb epitope compared with
25–30% for b1A. Similar results were obtained with
Figure 4. Effect of Mn11 on the conformation of b1B, b1A, and the
four mutants as detected by 12G10 mAb. (A) GD25-b1B (left) and
GD25-b1A (right) cells were analyzed by flow cytometry for surface
expression of the 12G10 mAb epitope in the presence or absence of
1 mM Mn11. As a control, cells were also stained with mAb 13,
which recognizes an Mn11-insensitive b1 epitope. GD25 cells were
used as a negative control. (B and C) The histograms show the level
of expression of the 12G10 mAb epitope in b1-transfected GD25 (B)
and CHO (C) cells in the absence (open bars) or presence (striped
bars) of 1 mM Mn11. Mean fluorescence intensities are expressed 6
SE as percentage of mAb 13 values and represent the mean of five
experiments.
Figure 3 (facing page). Adhesion and spreading of b1 variant-
transfected GD25 cells on fibronectin and laminin-1. Dishes were
coated with either fibronectin or laminin-1, and cells were plated in
serum-free medium for 1 h at 37°C. (A) The morphology of cells
adherent to fibronectin (10 mg/ml coating) is shown for GD25 (a),
GD25-b1B (b), GD25-b1A (c), GD25-b1TR (d), and GD25-b1COM
(e). (B) The morphology of the cells plated on laminin-1 (10 mg/ml
coating) in the absence (a–c) and presence of 1 mM Mn11 (d–f) is
shown for GD25 (a and d), GD25-b1B (b and e), and GD25-b1A
(c and f). Similar results were obtained using increasing doses of
laminin-1 up to 50 mg/ml. Note the severe reduction of spreading in
GD25-b1B cells both on fibronectin and laminin-1. Bars, 25 mm. (C)
The histograms show attachment of cells to 10 mg/ml of laminin-1
in the absence (open bars), in the presence of 1 mM Mn11 (slashed
bars), and in the presence of 1 mM Mn11 plus the b1 blocking mAb
AIIB2 (striped bars). Results are plotted 6 SE as percentage of input
cells and are the mean of three experiments. (D) The graph shows
cell attachment to increasing doses of fibronectin both in the absence
(closed symbols) and in the presence of 500 mg/ml of GRGDSP
peptide (open symbols). Adhesion is expressed as percentage of an
equal number of input cells. Symbols used are as follows: GD25 (Œ
and ‚), GD25-b1B (f and M), and GD25-b1A (F and E).
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mAb 9EG7 (Retta, Balzac, Ferraris, Belkin, Fässler,
Humphries, De Leo, Silengo, and Tarone, unpublished
results).
Expression of the above b1 variants in CHO cells
confirmed the data obtained with GD25 transfectans
(Figure 4C). Moreover, in the CHO system we also
found that b1DCOM-B and b1DCOM-A variants,
like b1B and b1COM, do not express the mAb 12G10
epitope unless exposed to Mn11 ions (Figure 4C).
These data show that all of the b1 variants ana-
lyzed changed the ectodomain conformation after
exposure to Mn11 ions. Despite this, after Mn11
activation only b1B, but none of the artificial b1
mutants, was able to support cell adhesion, thus
indicating that both the ectodomain conformation
and specific cytoplasmic subdomains are required
for adhesive function. The adhesive function of
Mn11-activated b1B, however, is not comparable to
that of b1A, because GD25-b1B cells cannot reach
full spreading (see Figure 3B, e).
b1B Inhibits Fibronectin Matrix Assembly
The assembly of fibronectin matrix in control and
transfected cells was evaluated by immunofluores-
cence staining of cell monolayers incubated with pu-
rified human plasma fibronectin as described in MA-
TERIALS AND METHODS.
GD25 untransfected cells assemble thin fibronectin
fibrils on the cell apical surface (Figure 5). This process
was inhibited by an aV-blocking antibody (Figure 5,
A, a and b, and B), indicating that aVb3/5 integrins
mediate matrix assembly in these cells as suggested
previously (Wennerberg et al., 1996). Expression of
b1B in GD25 cells resulted in dramatic inhibition of
fibronectin matrix assembly (Figure 5A, c), thus indi-
cating that b1B interferes with aV-containing endog-
enous integrins. Quantitative data, obtained by mea-
suring 125I-labeled fibronectin incorporation in a
detergent-insoluble matrix (Figure 5B), indicated a
fivefold reduction in matrix assembly in GD25-b1B
compared with parental cells. Interestingly, the ex-
pression of the two mutants b1COM (Figure 5A, e and
f) and b1TR (Retta, Balzac, Ferraris, Belkin, Fässler,
Humphries, De Leo, Silengo, and Tarone, unpublished
results) differed from b1B and did not interfere with
matrix assembly. Moreover, expression of b1A in
GD25 cells resulted in increased assembly of fibronec-
tin matrix compared with untransfected cells (Figure
5A, g and h).
To further analyze the b1B dominant negative effect,
we assayed the fibronectin matrix assembly ability of
CHO cells expressing the b1B or b1A isoform as well
as the four b1 mutants. As shown in Figure 6, also in
CHO cells the expression of b1B resulted in a domi-
nant negative effect; moreover, none of the other b1
constructs showed this ability. Exogenous fibronectin
assembly in these cells is driven by the a5b1-integrin,
because this function was blocked by the anti-hamster
a5b1 mAb PB1 (Retta, Balzac, Ferraris, Belkin, Fässler,
Humphries, De Leo, Silengo, and Tarone, unpublished
results). This result indicates that in CHO cells b1B
interferes with the endogenous a5b1 function.
Thus, the ability of b1B to block fibronectin matrix
assembly in both GD25 and CHO cells indicates that
this molecule is able to interfere with different classes
of integrins involved in this process.
Expression of b1-Integrin Variants Specifically
Affects Focal Adhesion and Stress Fiber
Organization
Given the fact that b1B impaired cell spreading and
fibronectin matrix assembly, we also examined its
ability to affect focal adhesion organization. As shown
in Figure 7a, GD25 cells form aV-containing promi-
nent focal adhesions when plated on fibronectin-
coated dishes, consistent with the reported ability of
aVb3 to support attachment to fibronectin in these
cells (Wennerberg et al., 1996). GD25-b1B cells plated
on fibronectin showed a clear reduction of aV-contain-
ing focal adhesions when compared with GD25 cells
(Figure 7, a and c). On the contrary, GD25-b1COM
(Figure 7e) and GD25-b1TR (Retta, Balzac, Ferraris,
Belkin, Fässler, Humphries, De Leo, Silengo, and
Tarone, unpublished results) cells did not show a re-
duction in aV-containing focal adhesions.
b1B, b1COM (Figure 7, d and f), and b1TR (Retta,
Balzac, Ferraris, Belkin, Fässler, Humphries, De Leo,
Silengo, and Tarone, unpublished results) molecules
were uniformly distributed on the cell surface, as
shown by immunofluorescence; thus b1B displaced
aV heterodimers without localizing to focal adhe-
sions.
We then tested whether focal adhesion localiza-
tion of cytoskeletal proteins, such as paxillin, and
actin organization were also affected. As shown in
Figure 8, b1B, but not b1A or b1COM, was able to
reduce the number of paxillin-containing focal ad-
Figure 5 (facing page). Exogenous fibronectin matrix assembly in
control and transfected GD25 cells in the presence of an anti-aV-
blocking antibody. (A) Confluent cell monolayers were cultured for
2 d with 200 nM human plasma fibronectin either in the absence (a,
c, e, and g) or in the presence (b, d, f, and h) of the inhibitory mAb
H9.2B8 against mouse aV, used to block the endogenous aV inte-
grins. Cells were then fixed for 10 min in 3.7% (v/v) paraformalde-
hyde in PBS, and the fibronectin in the matrix was stained by a
polyclonal antibody followed by a rhodamine-labeled anti-rabbit
IgG. Bar, 50 mm. (B) Biochemical evaluation of fibronectin matrix
assembly. 125I-labeled fibronectin incorporated into deoxycholate-
insoluble matrix of cells either in the absence (2) or in the presence
(1) of the aV-blocking H9.2B8 mAb was visualized by SDS-PAGE
and autoradiography. The molecular weight of reduced fibronectin
is shown.
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hesions (Figure 8a– g). Similar results were obtained
when we analyzed actin stress fibers. In fact, b1B-
expressing cells showed only residual stress fibers
in cell protrusions (Figure 8d), whereas cells ex-
pressing the other b1 constructs did not show sig-
nificant changes compared with untransfected cells
(Figure 8h). The interference of b1B on stress fiber
organization was also supported by analysis of cell
contractility by plating cells on silicon rubber films
(Harris et al., 1980; Danowski, 1989). As shown in
Figure 9, GD25 cells are able to pull on the substrate,
inducing wrinkles in the silicon film. On the other
hand, no wrinkles were observed in dishes seeded
with GD25-b1B cells. Altogether, these data show a
specific dominant negative effect of b1B on focal
adhesion and stress fiber organization.
b1B Has a Dominant Negative Effect on FAK
Tyrosine Phosphorylation
By plating CHO cells on dishes coated with antibodies
specific for the transfected human b1-integrin, we
have previously shown that b1B is unable to trigger
FAK tyrosine phosphorylation (Balzac et al., 1994).
Given the dominant negative effect of b1B on cell
adhesive functions, we tested the ability of this mole-
cule to interfere with endogenous integrin signaling.
CHO cells expressing different b1-integrin cytoplas-
mic variants were plated on dishes coated with anti-
hamster b1, antibody and tyrosine phosphorylation of
FAK was evaluated by Western blot. As shown in
Figure 10, A and B, endogenous hamster b1A had a
reduced capacity to induce FAK tyrosine phosphory-
lation in cells expressing b1B but not in cells express-
ing human b1A or the four b1 cytoplasmic domain
mutants (Figure 10C). At the same time, the four b1
mutants, like b1B, were not capable of triggering FAK
tyrosine phosphorylation to a significant extent (Fig-
ure 10D).
Association of Talin and a-Actinin with b1
Cytoplasmic Domain Variants
To evaluate the ability of different b1 cytoplasmic
domain variants to interact with talin, a-actinin, and
FAK, we performed coimmunoprecipitation studies
by extracting cells under mild detergent conditions
(see MATERIALS AND METHODS). As detected by
Western blots, talin was coprecipitated with b1A but
not with b1B, b1COM, or b1TR (Figure 11). On the
other hand, a-actinin was coprecipitated with b1A,
b1B, and b1COM but not with b1TR (Figure 11). The
amount of a-actinin associated with b1B and b1COM
immunoprecipitates, however, was reduced com-
pared with b1A immunoprecipitate.
Figure 6. Fibronectin matrix assembly in control and transfected CHO cells. Confluent cell monolayers were cultured for 2 d with 200 nM
human plasma fibronectin as described in MATERIALS AND METHODS. Cells were then fixed for 10 min in 3.7% (v/v) paraformaldehyde
in PBS, and the fibronectin in the matrix was stained by a specific polyclonal antibody followed by a rhodamine-labeled anti-rabbit IgG. Note
the dramatic reduction of fibronectin assembly in b1B-expressing cells. Bar, 80 mm.
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FAK was not detected in the immunocomplexes
associated with any of the four b1 molecules tested
(Retta, Balzac, Ferraris, Belkin, Fässler, Humphries, De
Leo, Silengo, and Tarone, unpublished results).
Figure 7. Localization of aV- and b1-integrin subunits to focal adhesion in control and transfected GD25 cells. Cells were plated on 10
mg/ml fibronectin-coated glass coverslips for 3 h in complete culture medium. Cells were then fixed for 10 min in 3.7% (v/v) paraformal-
dehyde in PBS, permeabilized with 0.5% Triton X-100 and 3.7% formaldehyde in PBS for 5 min, and stained for aV (A, C, E, G) or b1 (B, D,
F, H) integrins by specific antibodies followed by rhodamine-labeled secondary antibodies. Note the reduction of aV-containing focal
adhesion in b1B-transfected cells. Bar, 15 mm.
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S.F. Retta et al.
Molecular Biology of the Cell726
These data show that b1B is incapable of interacting
with talin but retains the ability to bind a-actinin. This
property is shared with b1COM variants.
DISCUSSION
We have previously shown that b1B, an integrin iso-
form with a distinct cytoplasmic domain, causes re-
duced cell spreading and migration when expressed
in CHO cells (Balzac et al., 1994). In the present study
we have examined the role of specific b1 cytoplasmic
subdomains in determining this dominant negative
function. To achieve this aim, we have constructed
four deletion mutants (see Figure 1): b1TR, lacking the
entire cytoplasmic domain; b1COM, lacking the cyto-
plasmic distal subdomain; and b1DCOM-B and
b1DCOM-A, in which the distal B and A subdomains
are linked to the transmembrane segment by deletion
of the common region.
These molecules were expressed both in GD25 cells,
which lack the endogenous b1 as a consequence of
gene knockout (Wennerberg et al., 1996), and in CHO
cells. Adhesion experiments in GD25 cells showed
that b1B is unable to support cell adhesion. In fact,
GD25-b1B cells, like untransfected GD25 cells, do not
adhere to laminin-1, despite correct surface expression
of a3b1B-, a5b1B-, and a6b1B-integrin heterodimers.
Moreover, b1B-containing heterodimers are not func-
tional in mediating adhesion to fibronectin. On the
other hand, b1A supports adhesion of GD25 cells to
laminin-1 and fibronectin. b1TR and b1COM behave
as b1B, being unable to support cell adhesion to lami-
nin-1.
The inability of b1B complexes to mediate cell ad-
hesion can be rescued by treating cells with Mn11
ions, which are known to increase binding affinity of
integrins for their ligands (Gailit and Ruoslahti, 1988).
Mn11 treatment, however, did not restore the adhe-
sive function of b1TR- and b1COM-transfected GD25
cells, indicating that the b1B cytoplasmic domain con-
fers specific adhesive function.
Mn11 ions affect conformation of the b1 ectodo-
main. This was confirmed by using 12G10 and 9EG7
mAbs, which recognize conformation-specific epi-
topes in the b1 ectodomain. Both mAbs bind very
poorly to b1B compared with b1A. Addition of Mn11
to the medium strongly increases 12G10 and 9EG7
mAb binding to b1B. Interestingly, b1TR, which does
not support adhesion to laminin-1 even in the pres-
ence of Mn11 ions, constitutively expresses 12G10 and
9EG7 epitopes, indicating that ectodomain conforma-
tion is not sufficient to endow b1 with adhesive prop-
Figure 9. Rubber substrate contractility assay. GD25, GD25-b1B, and GD25-b1A cells were plated for 1 d on silicone rubber substrata and
photographed under phase contrast. Note the incapacity of GD25-b1B cells to wrinkle the silicon substrate. Bar, 50 mm.
Figure 8 (facing page). Focal adhesion and stress fiber organiza-
tion in control and transfected GD25 cells. Cells were plated on 10
mg/ml fibronectin-coated glass coverslips for 3 h in complete cul-
ture medium. Cells were then fixed for 10 min in 3.7% (v/v) para-
formaldehyde in PBS, permeabilized with 0.5% Triton X-100 and
3.7% formaldehyde in PBS for 5 min, and double stained for paxillin
(A, C, E, G) and F-actin (B, D, F, H) as described in MATERIALS
AND METHODS. Note the reduction of stress fibers and paxillin-
containing focal adhesions in GD25-b1B cells. Bar, 10 mm.
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erties, but cytoplasmic sequences are also required.
On the other hand, the b1COM variant, similarly to
b1B, expresses 12G10 and 9EG7 epitopes in response
to Mn11, but it does not support cell adhesion. Thus,
the conserved common region of the b1 cytoplasmic
domain, present in the b1COM mutant, is not suffi-
cient to support cell adhesion but needs to be linked to
either the A or B distal subdomain. Although the
combination COM 1 A gives raise to a fully functional
molecule, COM 1 B is only partially functional, be-
cause it requires Mn11 to support attachment and
does not allow cell spreading.
The results presented show that b1B and the four b1
cytoplasmic domain mutants b1TR, b1COM,
b1DCOM-A, and b1DCOM-B are incapable of induc-
ing fibronectin matrix assembly. Interestingly, how-
ever, b1B shows a strong capacity to inhibit matrix
assembly controlled by endogenous integrins, a prop-
erty that is not shares by b1TR, b1COM, b1DCOM-A,
and b1DCOM-B. Fibronectin matrix assembly in-
volves different receptors in CHO and GD25 b1-null
cells. Although a5b1 is the major CHO integrin recep-
tor involved in this function, in GD25 cells this role is
played by aV-containing integrin complexes. The abil-
ity of b1B to inhibit fibronectin matrix assembly in
both cell types indicates a dominant negative effect on
both a5b1 and aVb3/b5 integrins. Work in progress
indicates that b1B also inhibits fibronectin matrix as-
sembly in epithelial cells and primary mouse fibro-
Figure 10. Inhibition of b1A-induced FAK tyrosine phosphoryla-
tion by b1B expression. To specifically trigger tyrosine phosphory-
lation of intracellular proteins mediated by the the endogenous or
transfected b1 integrins, cells were plated on plastic dishes coated
with the anti-hamster b1 mAb 7E2 (A–C) or with the anti-human b1
mAb TS2/16 (D), respectively. (A and B) Tyrosine phosphorylation
of total cellular proteins (A) and FAK (B) induced by endogenous
hamster b1A was detected by Western blotting with anti-phospho-
tyrosine mAb PY20. Note reduced tyrosine phosphorylation of 116-
to 130-kDa proteins (A) and FAK (B) in b1B-transfected CHO cells.
(B9) The reprobing of the blot with FAK antibodies is shown. (C) The
tyrosine phosphorylation of FAK via endogenous b1A was also
evaluated in CHO cells expressing the different cytoplasmic domain
mutants. Cells were plated on poly-l-lysine (lanes 1) for control and
on 7E2 mAb to endogenous hamster b1 (lanes 2). (C9) The reprobing
of the blot with FAK antibodies is shown. (D) The ability of the
different mutants to trigger FAK tyrosine phosphorylation directly
was evaluated by plating cells on mAb TS2/16 to the transfected
human b1 (lanes 29) or poly-l-lysine as control (lanes 1).
Figure 11. Association of talin and a-actinin with b1 cytoplasmic
domain variants. CHO cells transfected with b1B, b1A, b1COM,
and b1TR integrin variants were incubated in suspension with
TS2/16 mAb to human b1, and cells were lysated in digitonin-
containing buffer. Immunocomplexes were recovered from cell ex-
tracts with protein G-Sepharose beads and analyzed by Western
blotting with talin antibody. The blot was stripped and reprobed
with a-actinin antibody. Arrowheads point to the talin and a-actinin
bands.
S.F. Retta et al.
Molecular Biology of the Cell728
blasts, thus showing that this is a general property of
b1B in several cell types.
We also found a strong effect of b1B on focal adhe-
sion and actin stress fiber organization. In fact, in
GD25 cells that adhere to fibronectin via aVb3, b1B
expression led to a reduced number of aV-containing
focal adhesions. In these cells b1B is uniformly diffuse
at the cell surface but does not associate with the aV
subunit; thus reduction of aV localization to focal
adhesion cannot be explained by competitive dis-
placement. On the other hand, paxillin and F-actin
staining showed an overall reduction of focal adhe-
sions and stress fibers in GD25-b1B cells. This reduc-
tion could explain the GD25-b1B cells’ poor spreading
on fibronectin as well as the reduced contractility on
silicon rubber film. The interference with actin cy-
toskeleton organization is specific for the b1B isoform,
because neither b1TR nor b1COM leads to this effect.
To investigate at a molecular level the dominant
negative effects of b1B, we analyzed the signal trans-
duction ability of endogenous integrins in cells ex-
pressing the b1 cytoplasmic domain variants. The re-
sults obtained showed that b1B clearly exerts a
dominant negative effect on the ability of endogenous
b1 to trigger FAK tyrosine phosphorylation, whereas
neither b1A nor the four b1 mutants showed this
effect.
Altogether, these data show that b1B interferes with
adhesive functions of integrins by inhibiting FAK ty-
rosine phosphorylation, focal adhesion and stress fiber
organization, cell spreading, and fibronectin matrix
assembly. This dominant negative function is specific
to b1B.
Both the ectoplasmic and cytoplasmic domains of
b1B are functionally altered. We have shown, in fact,
that the b1B extracellular domain is exposed at the cell
surface in a conformation that cannot support cell
adhesion; in addition, b1B is defective in two proper-
ties depending on the cytoplasmic domain, namely
localization to focal adhesions and triggering of FAK
tyrosine phosphorylation (Balzac et al., 1994). Func-
tional analysis of the four b1 cytoplasmic domain
mutants presented in this work allows us to conclude
that the dominant negative effect does not depend on
the altered functional properties of the b1B ectodo-
main. In fact, the b1COM mutant, which is exposed at
the cell surface in a conformation that cannot support
cell adhesion like b1B, does not act as a dominant
negative molecule. Moreover, the b1TR mutant, lack-
ing the entire cytoplasmic domain, does not show a
dominant negative action. These data indicate that the
b1B cytoplasmic domain is responsible for the domi-
nant negative effect. In addition, the b1COM and
b1DCOM-B mutants indicate that the membrane prox-
imal common and the variable B subdomains alone
are not sufficient for this function. We can conclude
that the combination of common and B subdomains is
required to confer the dominant negative effect.
Among the possible mechanisms at the basis of the
dominant negative function, we can hypothesize that
b1B may act by generating specific negative signals, or
it may act by binding and sequestering cytoskeletal or
signaling molecules crucial for integrin function. The
latter possibility is less likely, as suggested by copre-
cipitation experiments; in fact, b1B did not bind talin
or FAK. b1B was able to bind a-actinin, however, but
this cannot account for the dominant negative effect,
because similar binding was also observed in the case
of b1COM, which does not act as dominant negative.
In conclusion, our data show that the specific link-
age of the b1 cytoplasmic common subdomain with
the variable A and B subdomains leads to specific
functional properties, suggesting that splicing in the
b1 cytoplasmic domain plays a key role in generating
b1 isoforms that may serve to regulate adhesive func-
tions specifically.
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